New device could accelerate the development of T-cell immunotherapies for cancer
Imperial researchers have invented a device that can rapidly select T-cells that are most effective at attacking cancer cells.
Feature
How can a human challenge study help tackle the global impact of Salmonella?
Dr Malick Gibani explains how a human challenge study for non-typhoidal Salmonella can support vaccine development and protect vulnerable populations.
Dame Lesley Regan appointed Government’s first Women’s Health Ambassador
A new role to help close the gender health gap and introduce the women’s health strategy in England has been filled by Professor Dame Lesley Regan.
Testosterone treatment does not increase risk of heart attack
Men taking testosterone therapy are at no greater risk of heart attack during their first year of treatment.
£3m NIHR funding boost for digital diagnostics in African healthcare systems
A new £3m NIHR award will see Imperial and 13 institutions collaborate to research and develop digital diagnostics for African healthcare systems.
New centres should bring diagnosis to the people
NHS Community Diagnostic Centres must stay true to their mission if the public is to benefit, according to a study by Imperial researchers.
Improvement-focused approach needed in NHS complaint-handling policies
National policies for complaint handling in NHS hospitals in England may be missing opportunities for learning from the concerns raised.
Thinking to the future: Incubator companies grow White City ecosystem
Three life sciences startups have graduated from the Imperial White City Incubator and moved into their own spaces in the White City area.
Imperial startup joins forces with QMUL on medtech to help Parkinson's sufferers
Charco Neurotech, founded at Imperial, will work with Queen Mary University of London, to test its device for alleviating the symptoms of Parkinson’s.
1
Blood pressure control and mask immunotherapy: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
